aluates Reports

$ 0.0

Automative

Global Prostate Cancer Diagnostics Market Research Report 2026

Published Date: 2026-01-16

Report Code: QYRE-Auto-21D9278

Global Prostate Cancer Diagnostics Market Insights and Forecast to 2028

BUY CHAPTERS

Global Prostate Cancer Diagnostics Market Research Report 2026

Code: QYRE-Auto-21D9278

Report

2026-01-16

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Genomic Health

Abbott

Beckman Coulter

Biomeriux

Roche

MDx Health

DiaSorin

Myriad Genetics

Ambry Genetics

Siemens Healthcare

OPKO

Prostate Cancer Diagnostics Market Size

The global Prostate Cancer Diagnostics market was valued at US$ 16680 million in 2025 and is anticipated to reach US$ 28020 million by 2032, at a CAGR of 7.8% from 2026 to 2032.

Prostate Cancer Diagnostics Market

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

This report delivers a comprehensive overview of the global Prostate Cancer Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prostate Cancer Diagnostics. The Prostate Cancer Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Prostate Cancer Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Prostate Cancer Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Prostate Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Prostate Cancer Diagnostics Market
Accounted market size in 2025	US$ 16680 million
Forecasted market size in 2032	US$ 28020 million
CAGR	7.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Tumor Biomarker Tests Imaging Biopsy Other
Segment by Application	Age Below 55 Age 55-75 Age Above 75
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Prostate Cancer Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Diagnostics Market growing?

Ans: The Prostate Cancer Diagnostics Market witnessing a CAGR of 7.8% during the forecast period 2026-2032.

What is the Prostate Cancer Diagnostics Market size in 2032?

Ans: The Prostate Cancer Diagnostics Market size in 2032 will be US$ 28020 million.

What is the Prostate Cancer Diagnostics Market share by region?

Ans: North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

Who are the main players in the Prostate Cancer Diagnostics Market report?

Ans: The main players in the Prostate Cancer Diagnostics Market are OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics

What are the Application segmentation covered in the Prostate Cancer Diagnostics Market report?

Ans: The Applications covered in the Prostate Cancer Diagnostics Market report are Age Below 55, Age 55-75, Age Above 75

What are the Type segmentation covered in the Prostate Cancer Diagnostics Market report?

Ans: The Types covered in the Prostate Cancer Diagnostics Market report are Tumor Biomarker Tests, Imaging, Biopsy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Tumor Biomarker Tests

1.2.3 Imaging

1.2.4 Biopsy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Prostate Cancer Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Age Below 55

1.3.3 Age 55-75

1.3.4 Age Above 75

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Diagnostics Market Perspective (2021–2032)

2.2 Global Prostate Cancer Diagnostics Growth Trends by Region

2.2.1 Global Prostate Cancer Diagnostics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Prostate Cancer Diagnostics Historic Market Size by Region (2021–2026)

2.2.3 Prostate Cancer Diagnostics Forecasted Market Size by Region (2027–2032)

2.3 Prostate Cancer Diagnostics Market Dynamics

2.3.1 Prostate Cancer Diagnostics Industry Trends

2.3.2 Prostate Cancer Diagnostics Market Drivers

2.3.3 Prostate Cancer Diagnostics Market Challenges

2.3.4 Prostate Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Diagnostics Players by Revenue

3.1.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2021–2026)

3.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2021–2026)

3.2 Global Top Prostate Cancer Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Prostate Cancer Diagnostics Revenue

3.4 Global Prostate Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2025

3.5 Global Key Players of Prostate Cancer Diagnostics Head Offices and Areas Served

3.6 Global Key Players of Prostate Cancer Diagnostics, Products and Applications

3.7 Global Key Players of Prostate Cancer Diagnostics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics Breakdown Data by Type

4.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2021–2026)

4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2027–2032)

5 Prostate Cancer Diagnostics Breakdown Data by Application

5.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2021–2026)

5.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Prostate Cancer Diagnostics Market Size (2021–2032)

6.2 North America Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Prostate Cancer Diagnostics Market Size by Country (2021–2026)

6.4 North America Prostate Cancer Diagnostics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Diagnostics Market Size (2021–2032)

7.2 Europe Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Prostate Cancer Diagnostics Market Size by Country (2021–2026)

7.4 Europe Prostate Cancer Diagnostics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Diagnostics Market Size (2021–2032)

8.2 Asia-Pacific Prostate Cancer Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2021–2026)

8.4 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Prostate Cancer Diagnostics Market Size (2021–2032)

9.2 Latin America Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Prostate Cancer Diagnostics Market Size by Country (2021–2026)

9.4 Latin America Prostate Cancer Diagnostics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Diagnostics Market Size (2021–2032)

10.2 Middle East & Africa Prostate Cancer Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2021–2026)

10.4 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 OPKO

11.1.1 OPKO Company Details

11.1.2 OPKO Business Overview

11.1.3 OPKO Prostate Cancer Diagnostics Introduction

11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.1.5 OPKO Recent Development

11.2 Genomic Health

11.2.1 Genomic Health Company Details

11.2.2 Genomic Health Business Overview

11.2.3 Genomic Health Prostate Cancer Diagnostics Introduction

11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.2.5 Genomic Health Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Prostate Cancer Diagnostics Introduction

11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.3.5 Abbott Recent Development

11.4 Beckman Coulter

11.4.1 Beckman Coulter Company Details

11.4.2 Beckman Coulter Business Overview

11.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction

11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.4.5 Beckman Coulter Recent Development

11.5 Siemens Healthcare

11.5.1 Siemens Healthcare Company Details

11.5.2 Siemens Healthcare Business Overview

11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction

11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.5.5 Siemens Healthcare Recent Development

11.6 bioMeriux

11.6.1 bioMeriux Company Details

11.6.2 bioMeriux Business Overview

11.6.3 bioMeriux Prostate Cancer Diagnostics Introduction

11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.6.5 bioMeriux Recent Development

11.7 Roche

11.7.1 Roche Company Details

11.7.2 Roche Business Overview

11.7.3 Roche Prostate Cancer Diagnostics Introduction

11.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.7.5 Roche Recent Development

11.8 MDx Health

11.8.1 MDx Health Company Details

11.8.2 MDx Health Business Overview

11.8.3 MDx Health Prostate Cancer Diagnostics Introduction

11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.8.5 MDx Health Recent Development

11.9 DiaSorin

11.9.1 DiaSorin Company Details

11.9.2 DiaSorin Business Overview

11.9.3 DiaSorin Prostate Cancer Diagnostics Introduction

11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.9.5 DiaSorin Recent Development

11.10 Myriad Genetics

11.10.1 Myriad Genetics Company Details

11.10.2 Myriad Genetics Business Overview

11.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction

11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.10.5 Myriad Genetics Recent Development

11.11 Ambry Genetics

11.11.1 Ambry Genetics Company Details

11.11.2 Ambry Genetics Business Overview

11.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction

11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2021–2026)

11.11.5 Ambry Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Genomic Health

Abbott

Beckman Coulter

Biomeriux

Roche

MDx Health

DiaSorin

Myriad Genetics

Ambry Genetics

Siemens Healthcare

OPKO

List of Tables

Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Tumor Biomarker Tests

Table 3. Key Players of Imaging

Table 4. Key Players of Biopsy

Table 5. Key Players of Other

Table 6. Global Prostate Cancer Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Prostate Cancer Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Prostate Cancer Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 9. Global Prostate Cancer Diagnostics Market Share by Region (2021–2026)

Table 10. Global Prostate Cancer Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Prostate Cancer Diagnostics Market Share by Region (2027–2032)

Table 12. Prostate Cancer Diagnostics Market Trends

Table 13. Prostate Cancer Diagnostics Market Drivers

Table 14. Prostate Cancer Diagnostics Market Challenges

Table 15. Prostate Cancer Diagnostics Market Restraints

Table 16. Global Prostate Cancer Diagnostics Revenue by Players (US$ Million), 2021–2026

Table 17. Global Prostate Cancer Diagnostics Market Share by Players (2021–2026)

Table 18. Global Top Prostate Cancer Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Prostate Cancer Diagnostics Revenue, 2025

Table 19. Ranking of Global Top Prostate Cancer Diagnostics Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Prostate Cancer Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Prostate Cancer Diagnostics, Products and Applications

Table 23. Global Key Players of Prostate Cancer Diagnostics, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Prostate Cancer Diagnostics Market Size by Type (US$ Million), 2021–2026

Table 26. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2021–2026)

Table 27. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2027–2032)

Table 29. Global Prostate Cancer Diagnostics Market Size by Application (US$ Million), 2021–2026

Table 30. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2021–2026)

Table 31. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2027–2032)

Table 33. North America Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 35. North America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 48. OPKO Company Details

Table 49. OPKO Business Overview

Table 50. OPKO Prostate Cancer Diagnostics Product

Table 51. OPKO Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 52. OPKO Recent Development

Table 53. Genomic Health Company Details

Table 54. Genomic Health Business Overview

Table 55. Genomic Health Prostate Cancer Diagnostics Product

Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 57. Genomic Health Recent Development

Table 58. Abbott Company Details

Table 59. Abbott Business Overview

Table 60. Abbott Prostate Cancer Diagnostics Product

Table 61. Abbott Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 62. Abbott Recent Development

Table 63. Beckman Coulter Company Details

Table 64. Beckman Coulter Business Overview

Table 65. Beckman Coulter Prostate Cancer Diagnostics Product

Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 67. Beckman Coulter Recent Development

Table 68. Siemens Healthcare Company Details

Table 69. Siemens Healthcare Business Overview

Table 70. Siemens Healthcare Prostate Cancer Diagnostics Product

Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 72. Siemens Healthcare Recent Development

Table 73. bioMeriux Company Details

Table 74. bioMeriux Business Overview

Table 75. bioMeriux Prostate Cancer Diagnostics Product

Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 77. bioMeriux Recent Development

Table 78. Roche Company Details

Table 79. Roche Business Overview

Table 80. Roche Prostate Cancer Diagnostics Product

Table 81. Roche Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 82. Roche Recent Development

Table 83. MDx Health Company Details

Table 84. MDx Health Business Overview

Table 85. MDx Health Prostate Cancer Diagnostics Product

Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 87. MDx Health Recent Development

Table 88. DiaSorin Company Details

Table 89. DiaSorin Business Overview

Table 90. DiaSorin Prostate Cancer Diagnostics Product

Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 92. DiaSorin Recent Development

Table 93. Myriad Genetics Company Details

Table 94. Myriad Genetics Business Overview

Table 95. Myriad Genetics Prostate Cancer Diagnostics Product

Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 97. Myriad Genetics Recent Development

Table 98. Ambry Genetics Company Details

Table 99. Ambry Genetics Business Overview

Table 100. Ambry Genetics Prostate Cancer Diagnostics Product

Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (US$ Million), 2021–2026

Table 102. Ambry Genetics Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Prostate Cancer Diagnostics Picture

Figure 2. Global Prostate Cancer Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Prostate Cancer Diagnostics Market Share by Type: 2025 vs 2032

Figure 4. Tumor Biomarker Tests Features

Figure 5. Imaging Features

Figure 6. Biopsy Features

Figure 7. Other Features

Figure 8. Global Prostate Cancer Diagnostics Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Prostate Cancer Diagnostics Market Share by Application: 2025 vs 2032

Figure 10. Age Below 55 Case Studies

Figure 11. Age 55-75 Case Studies

Figure 12. Age Above 75 Case Studies

Figure 13. Prostate Cancer Diagnostics Report Years Considered

Figure 14. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Prostate Cancer Diagnostics Market Share by Region: 2025 vs 2032

Figure 17. Global Prostate Cancer Diagnostics Market Share by Players in 2025

Figure 18. Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2025

Figure 20. North America Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Prostate Cancer Diagnostics Market Share by Country (2021–2032)

Figure 22. United States Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Prostate Cancer Diagnostics Market Share by Country (2021–2032)

Figure 26. Germany Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Prostate Cancer Diagnostics Market Share by Region (2021–2032)

Figure 34. China Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Prostate Cancer Diagnostics Market Share by Country (2021–2032)

Figure 42. Mexico Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2021–2032)

Figure 46. Israel Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Prostate Cancer Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 50. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 51. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 52. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 53. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 54. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 55. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 56. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 57. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 58. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 59. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prostate Cancer Medicine Market Insights Forecast to 2030

Global Prostate Cancer Market Insights Forecast to 2030

Global Handed Prostate Biopsy Device Market Research Report 2024

Global Prostate Cancer Diagnostics and Treatment Market Research Report 2025

Global Bladder Cancer Therapeutics and Diagnostics Market Research Report 2024

Global Oncology Therapeutic Drug Market Research Report 2024

BPH Treatment Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Drugs Market Insights Forecast to 2030

Oncology Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs for Oncology Market Insights Forecast to 2030

Global Prostate Specific Antigen PSA Biomarker Market Insights Forecast to 2030

Global Kidney Cancer or Renal Cancer Market Research Report 2024

Global Prostate Cancer Diagnostics Solution Market Research Report 2025

Benign Prostatic Hyperplasia BPH Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Benign Prostatic Hyperplasia BPH Drugs Market Insights Forecast to 2030

Global Kidney Cancer Therapeutics Market Research Report 2025

Oncology Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Biopsies Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Drugs for Benign Prostatic Hyperplasia Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions